Health Care • Industrial Specialties
$8.77 ▼ -0.18
(-2.01%)
MKT CAP: $101.7M • VOL: 149.8K
52W L $1 52W H $13
ROARABLE / RQD
D- • 37/100
PIOTROSKI
1 / 9
AGPU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $0 | $84.8K | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | — | $6.5K | — |
| Gross Margin % | — | 7.7% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$180.9M | -$10.3M | -$11.1M |
| Operating Margin % | — | -80.0% | — |
| Net Income (GAAP) | -$233.1M | -$12.7M | -$14.0M |
| EBITDA (Normalized) | -$180.9M | -$10.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | — | — | -$13.2M |
| Capital Expenditures (CapEx) | $0 | $9.5K | — |
| Free Cash Flow (FCF) | — | — | -$13.2M |
| FCF Margin % | — | — | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $10.8M | $611.8K | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $47.7M | -$202.6K | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AGPU.